Hopefully they follow thru with some major publications this year like Stamler mentioned previously. Who knows though. I would really like to get an update on the clinical path for pbt2. can it move forward right away in acute settings? are they meeting with fda in regards to chronic administration?
- Forums
- ASX - By Stock
- Stamler and Bradbury work still for TEVA
Hopefully they follow thru with some major publications this...
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
-0.001(11.1%) |
Mkt cap ! $20.98M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.4¢ | $14.55K | 3.241M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
62 | 71906262 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 32338803 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
59 | 71406262 | 0.004 |
55 | 50902564 | 0.003 |
16 | 38864402 | 0.002 |
14 | 93470101 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 32288803 | 24 |
0.006 | 34096588 | 15 |
0.007 | 16220649 | 14 |
0.008 | 14855575 | 14 |
0.009 | 8000000 | 6 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online